A Breakthrough in Early Autism Diagnosis

Golden Steps ABA proudly offers EarliPoint — an FDA-authorized eye-tracking technology that helps identify signs of autism as early as 16 months.

Fill Out This Form to Schedule Your Assessment

Name

Phone

address (honeypot)

Message

Study Locations

EarliPoint is a medical technology company focused on supporting clinicians in the early evaluation of autism spectrum disorder (ASD). Founded by researchers from institutions including Yale University and Emory University School of Medicine

Understanding Autism Starts with Seeing Differently

EarliPoint helps doctors and families understand how a child engages with the world. By tracking a child’s eye movements while they watch short videos, EarliPoint reveals how they respond to social and emotional cues — offering measurable data that supports early autism diagnosis.

Early Detection

Identify signs of autism as early as 16 months.

Objective Insights

Backed by 15+ years of research and clinical validation

Non-Invasive

A clinician-administered, 10-minute eye-tracking session.

What our customers say

Success to resolve my issue quickly and efficiently, and their friendly and helpful made the experience even better.

Malik Wihowo

Creative Director @Tailwind

Success to resolve my issue quickly and efficiently, and their friendly and helpful made the experience even better.

Malik Wihowo

Creative Director @Tailwind

See Your Child’s Progress with Clear, Meaningful Reports

Every EarliPoint evaluation provides simple, visual reports that help you understand your child’s development, track growth over time, and take confident next steps with your care team.

Diagnostic Report

Get Answers

EarliPoint compares your child’s eye-tracking patterns to validated clinical data to help identify signs of autism. The report breaks down key measures like social engagement, verbal ability, and nonverbal learning — giving you and your provider clear, objective insight into your child’s development.

Progress Report

See Growth Over Time

With repeated assessments, EarliPoint helps track your child’s progress as therapy and learning continue. Each report shows how communication, attention, and social understanding evolve — helping you and your care team see measurable improvement over time.

Summary Report

Insights That Guide Next Steps

Every EarliPoint evaluation includes an easy-to-read summary highlighting your child’s unique developmental profile. Visual charts and clear explanations make it simple to understand results and plan the right next steps for support and growth.

How It Works

Watch

Your child watches short, engaging videos on the EarliPoint device.

Track

Eye-tracking technology measures where and how your child looks — capturing key moments of attention and engagement.

Understand

Your provider reviews the results and discusses what they reveal about your child’s development and possible signs of autism.

Frequently Asked Questions

What is the EarliPoint System?

The EarliPoint System is an FDA-cleared medical device indicated for use as a tool to aid qualified clinicians in the diagnosis and assessment of Autism Spectrum Disorder (ASD) in children 16 to 30 months old who are at risk based on concerns shared by a parent, caregiver, or healthcare provider.

(Not for direct consumer purchase; clinician use only).

How does the EarliPoint System work?

Does EarliPoint give a diagnosis of autism?

Is the EarliPoint System safe for my child?

What are the limitations of the EarliPoint System?

Get Answers. Gain Peace of Mind.

Golden Steps ABA is proud to offer EarliPoint — giving families the clarity and confidence they need early in their journey.